Diagnostics virtual summit: Advancing the future of diagnostics
Advances in molecular biology, immunodiagnostics and rapid point-of-care (POC) testing are transforming diagnostics. Our interactive virtual summit showcases recently launched technologies, products and solutions to support the development of diagnostics now and in the future. Incorporating a program of webinars, panel discussions, thought-leadership content as well as sessions from Cytiva’s own application specialists.
Cytiva’s direct RT-qPCR chemistry broadens the spectrum of viral nucleic acids targets and pathogens that can be detected directly from unpurified samples, reducing the time required for nucleic acid amplification testing (NAAT) and increasing RNA stability in the sample.
WEBINAR: Mitigating risks and optimizing security of supply in diagnostics
Find out how a data-led approach supports the development and implementation of measures to maintain supply levels and meet the expectations of diagnostics customers even in uncertain times. The webinar also highlights some of the workflow considerations that can help customers reduce supply risks.
New application note: Sensitive detection of RNA and DNA viruses such as: Adenovirus (Type 14), Influenza A (H3N2) and COVID-19 with Sera-Xtracta Virus/Pathogen Kit
Sera-Xtracta Virus Pathogen Kit gives efficient total nucleic acid (DNA/RNA) recovery from swabs, biofluids and transport media and in different concentrations with high sensitivity in downstream detection. The data suggests that this kit and the RNAspin Mini Kit can help address the demand for a universal extraction kit which copurifies both DNA and RNA or just RNA and can help address the current challenges faced with supplying kits for COVID-19 testing.
Choose from our wide range of solutions designed for rapid nucleic acid purification and amplification of DNA and RNA. From spin columns to amplification kits, we can support your purification workflows in multiple applications.
Our online application notes library allows you to search for independent, peer-reviewed scientific articles and case studies which demonstrate the performance and clinical success of products from across our portfolio when used with different technologies such as NGS or microarrays, or different sample types such as FFPE or blood.
Nucleic acid sequencing technologies have transformed the genetics and diagnostics fields, from the first Sanger sequencing of the human genome to whole population studies using the latest NGS technologies.
Genome sequencing allows disease diagnosis at an earlier stage and with the discovery of relevant biomarkers it means that more targeted therapeutic interventions can be provided. The trend towards a more personalized approach to healthcare is one reason for the continued growth in molecular diagnostics.
From infectious diseases and cancers to metabolic disorders and cardiac health, immunodiagnostics provides highly sensitive and specific insights into a wide range of conditions, enabling the development of specific treatments and therapies.
Our custom biology, conjugation, contract manufacturing and Lyo-Stable solutions can be tailored to your needs, enabling faster commercialization of your assay with minimal disruption to your existing protocols.
